Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. ViewRay, Inc.
  6. News
  7. Summary
    VRAY   US92672L1070

VIEWRAY, INC.

(VRAY)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Insider Trends: Insider Adds to Selling Trend at ViewRay

06/10/2021 | 07:05am EDT


ę MT Newswires 2021
All news about VIEWRAY, INC.
09/16VIEWRAY : reg; to Partcipate in the Cantor Global Healthcare Conference
PR
09/10VIEWRAY, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
08/27VIEWRAY : reg; to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
PR
08/24VIEWRAY : Amsterdam University Medical Centers establishes same-day ablative treatment ser..
PR
08/24ViewRay, Inc. Announces Amsterdam University Medical Centers Establishes Same-Day Ablat..
CI
08/17VIEWRAY : UCLA Health Treats its 1,000th Patient Using MRIdian« MRI-Guided Radiation Thera..
PR
08/06VIEWRAY : Q2 Loss Widens, Trails Estimates; Issues FY21 Outlook; Stock Slumps 17%
MT
08/06VIEWRAY : Management's Discussion and Analysis of Financial Condition and Results of Opera..
AQ
08/05VIEWRAY : Q2 Earnings Snapshot
AQ
08/05VIEWRAY, INC. : Results of Operations and Financial Condition, Regulation FD Disclosure, F..
AQ
More news
Analyst Recommendations on VIEWRAY, INC.
More recommendations
Financials (USD)
Sales 2021 68,8 M - -
Net income 2021 -111 M - -
Net cash 2021 99,5 M - -
P/E ratio 2021 -10,4x
Yield 2021 -
Capitalization 1 173 M 1 173 M -
EV / Sales 2021 15,6x
EV / Sales 2022 9,97x
Nbr of Employees 236
Free-Float 97,0%
Chart VIEWRAY, INC.
Duration : Period :
ViewRay, Inc. Technical Analysis Chart | VRAY | US92672L1070 | MarketScreener
Technical analysis trends VIEWRAY, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Last Close Price 7,14 $
Average target price 8,00 $
Spread / Average Target 12,0%
EPS Revisions
Managers and Directors
Scott William Drake President, Chief Executive Officer & Director
Zachary Stassen Chief Financial Officer
Daniel Jeffrey Moore Chairman
James F. Dempsey Chief Scientific Officer
Martin Fuss Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
VIEWRAY, INC.86.91%1 114
THERMO FISHER SCIENTIFIC30.58%238 660
DANAHER CORPORATION46.32%231 396
INTUITIVE SURGICAL, INC.25.71%122 378
SIEMENS HEALTHINEERS AG40.16%77 521
EDWARDS LIFESCIENCES CORPORATION29.89%74 587